Kopran (BOM:524280) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524280 Kopran Ltd BOM:524280
69 GF Score
Price ₹200.60
GF Value ₹215.74
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Kopran FFO per Share?

FFO per Share only applies to REITs.

BOM:524280
69GF Score
Kopran Ltd BOM:524280
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kopran (BOM:524280) Overvalued in 2026?

Based on GuruFocus' analysis, Kopran stock appears to be undervalued. The current stock price of ₹200.60 is trading 7% below its estimated GF Value™ of ₹215.74. GuruFocus considers Kopran to be Fairly Valued.

Key valuation signals for BOM:524280:

  • FFO per Share:
  • GF Value™: ₹215.74 vs. price of ₹200.60 (7% below fair value)
  • GF Score™: 69/100 with 8 warning signs

No single metric tells the full story. See the BOM:524280 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kopran Business Description

Other Exchanges KOPRAN:India
Address Dr. E. Moses Road, 1076, Parijat House, Worli, Mumbai, MH, IND, 400 018
Kopran Ltd is an Indian based pharmaceutical company. It is engaged in manufacturing of Formulation (Finished Dosage Form) and Active Pharmaceutical Ingredients (API) i.e., Pharmaceuticals. It manufactures dosage forms including, tablets, capsules, dry powder, suspension, and injectables. Some of its product range includes antibiotics, cardiovascular, anti-diabetes, respiratory, pain management, and gastrointestinal. Geographically, it has a presence in India; South Africa; Ethiopia; Zambia; Egypt; Jordan and Rest of World.
69GF Score

Get the complete analysis for BOM:524280

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹200.60
Price
₹215.74
GF Value